Antidepressant Use and Diabetes Mellitus Risk: A Meta-Analysis

키워드

참고문헌 (50)

1. Niska R, "National Hospital Ambulatory Medical Care Survey: 2007 emergency department summary", Natl Health Stat Report, (26), pp.1~31 (2010)
2. Moret C, "Antidepressants in the treatment of fibromyalgia", Neuropsychiatr Dis Treat, 2, pp.537~548 (2006)
3. Grady D, "Clinical practice: management of menopausal symptoms", N Engl J Med, 355, pp.2338~2347 (2006)
4. Zimmermann U, "Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients", J Psychiatr Res, 37, pp.193~220 (2003)
5. Blaber MS, "“Lipid rescue” for tricyclic antidepressant cardiotoxicity", J Emerg Med, 43, pp.465~467 (2012)
6. Smoller JW, "Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women’s Health Initiative study", Arch Intern Med, 169, pp.2128~2139 (2009)
7. Ma Y, "Elevated depressive symptoms, antidepressant use, and diabetes in a large multiethnic national sample of postmenopausal women", Diabetes Care, 34, pp.2390~2392 (2011)
8. Jerrell JM, "Neuroendocrine-related adverse events associated with antidepressant treatment in children and adolescents", CNS Neurosci Ther, 16, pp.83~90 (2010)
9. Kivimaki M, "Antidepressant medication use, weight gain, and risk of type 2 diabetes: a population-based study", Diabetes Care, 33, pp.2611~2616 (2010)
10. Raeder MB, "Obesity, dyslipidemia, and diabetes with selective serotonin reuptake inhibitors: the Hordaland Health Study", J Clin Psychiatry, 67, pp.1974~1982 (2006)
11. Knol MJ, "No increased incidence of diabetes in antidepressant users", Int Clin Psychopharmacol, 22, pp.382~386 (2007)
12. McIntyre RS, "The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms", Expert Opin Drug Saf, 5, pp.157~168 (2006)
13. Derijks HJ, "The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports", Eur J Clin Pharmacol, 64, pp.531~538 (2008)
14. Wilkins TL, "Antidepressant use, depression, lifestyle factors, and new-onset diabetes", Int Clin Psychopharmacol, 26, pp.159~168 (2011)
15. Stroup DF, "Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group", JAMA, 283, pp.2008~12 (2000)
16. Wells GA, "The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses", Proceedings of the 3rd symposium on systematic reviews: beyond the basics, pp.3~5 (2000), Centre for Statistics in Medicine
17. Higgins JP, "Measuring inconsistency in meta-analyses", BMJ, 327, pp.557~560 (2003)
18. Mantel N, "Statistical aspects of the analysis of data from retrospective studies of disease, In The challenge of epidemiology: issues and selected readings", pp.533~553 (2004), Pan American Health Organization
19. DerSimonian R, "Meta-analysis in clinical trials", Control Clin Trials, 7, pp.177~188 (1986)
20. Brown LC, "Type of antidepressant therapy and risk of type 2 diabetes in people with depression", Diabetes Res Clin Pract, 79, pp.61~67 (2008)
21. Campayo A, "Depressive disorder and incident diabetes mellitus: the effect of characteristics of depression", Am J Psychiatry, 167, pp.580~588 (2010)
22. Carvalho F, "Hyperglycemia induced by acute central fluoxetine administration: role of the central CRH system and 5-HT3 receptors", Neuropeptides, 38, pp.98~105 (2004)
23. Knol MJ, "Influence of antidepressants on glycaemic control in patients with diabetes mellitus", Pharmacoepidemiol Drug Saf, 17, pp.577~586 (2008)
24. Manderbacka K, "Diabetes and depression? Secular trends in the use of antidepressants among persons with diabetes in Finland in 1997-2007", Pharmacoepidemiol Drug Saf (2010)
25. Shehatah A, "Prevalence and correlates of depressive disorders in elderly with type 2 diabetes in primary health care settings", J Affect Disord, 123, pp.197~201 (2010)
26. van Reedt Dortland AK, "Associations between serum lipids and major depressive disorder: results from the Netherlands Study of Depression and Anxiety (NESDA)", J Clin Psychiatry, 71, pp.729~736 (2010)
27. van Reedt Dortland AK, "Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use", Acta Psychiatr Scand, 122, pp.30~39 (2010)
28. Antai-Otong D., "The art of prescribing. Risks and benefits of non-benzodiazepine receptor agonists in the treatment of acute primary insomnia in older adults", Perspect Psychiatr Care, 42, pp.196~200 (2006)
29. Jindal RD, "Long-term antidepressant use and risk for diabetes: cause for concern and optimism", Am J Psychiatry, 166, pp.1065~1066 (2009)
30. Zaharan NL, "Antidepressants and newonset diabetes in the irish primary care population", Pharmacoepidemiol Drug Saf, 19, pp.657~658 (2010)
31. Rubin RR, "Depression symptoms and antidepressant medicine use in Diabetes Prevention Program participants", Diabetes Care, 28, pp.830~837 (2005)
32. Rubin RR, "Cardiovascular disease risk factors, depression symptoms and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes", Diabetologia, 53, pp.1581~1589 (2010)
33. Pan A, "Use of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults", Diabetologia, 55, pp.63~72 (2012)
34. Rubin RR, "Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program", Diabetes Care, 31, pp.420~426 (2008)
35. Khoza S, "Use of antidepressant agents and the risk of type 2 diabetes", Eur J Clin Pharmacol, 68, pp.1295~1302 (2012)
36. Andersohn F, "Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus", Am J Psychiatry, 166, pp.591~598 (2009)
37. Atlantis E, "Diabetes incidence associated with depression and antidepressants in the Melbourne Longitudinal Studies on Healthy Ageing (MELSHA)", Int J Geriatr Psychiatry, 25, pp.688~696 (2010)
38. Geddes JR, "WITHDRAWN: Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression", Cochrane Database Syst Rev, (3), pp.CD001851~ (2007)
39. Sclar DA, "Trends in the prescribing of antidepressant pharmacotherapy: office-based visits, 1990-1995", Clin Ther, 20, pp.871~884 (1998)
40. Olfson M, "Trends in the prescription of antidepressants by office-based psychiatrists", Am J Psychiatry, 150, pp.571~577 (1993)
41. Fava M, "Weight gain and antidepressants", J Clin Psychiatry, 61(Suppl 11), pp.37~41 (2000)
42. Mann JJ, "The medical management of depression", N Engl J Med, 353, pp.1819~1834 (2005)
43. Fava M, "Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment", J Clin Psychiatry, 61, pp.863~867 (2000)
44. Knol MJ, "Depression as a risk factor for the onset of type 2 diabetes mellitus: a meta-analysis", Diabetologia, 49, pp.837~845 (2006)
45. Mezuk B, "Depression and type 2 diabetes over the lifespan: a meta-analysis", Diabetes Care, 31, pp.2383~2390 (2008)
46. Bonnet F, "Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease", Atherosclerosis, 178, pp.339~344 (2005)
47. Sugimoto Y, "Involvement of serotonin in zimelidine-induced hyperglycemia in mice", Biol Pharm Bull, 22, pp.1240~1241 (1999)
48. Levkovitz Y, "Antidepressants induce cellular insulin resistance by activation of IRS-1 kinases", Mol Cell Neurosci, 36, pp.305~312 (2007)
49. Larsen P, "Wiliams textbook of endocrinology" (2003), Saunders
50. Gilon P, "Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function", Endocr Rev, 22, pp.565~604 (2001)

관련 논문AI추천